HITI gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 191 industry peers in the Pharmaceuticals industry. HITI has a medium profitability rating, but doesn't score so well on its financial health evaluation. HITI is not valued too expensively and it also shows a decent growth rate.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.54% | ||
| ROE | -57.92% | ||
| ROIC | 5.17% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.74% | ||
| PM (TTM) | N/A | ||
| GM | 25.99% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.94 | ||
| Debt/FCF | 8.31 | ||
| Altman-Z | 1.6 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.37 | ||
| Quick Ratio | 0.7 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 24.09 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.2 | ||
| EV/EBITDA | 8.42 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
2.35
+0.08 (+3.52%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 24.09 | ||
| P/S | 0.47 | ||
| P/FCF | 21.2 | ||
| P/OCF | 11.74 | ||
| P/B | 3.2 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.42 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.54% | ||
| ROE | -57.92% | ||
| ROCE | 6.54% | ||
| ROIC | 5.17% | ||
| ROICexc | 6.4% | ||
| ROICexgc | 17.98% | ||
| OM | 2.74% | ||
| PM (TTM) | N/A | ||
| GM | 25.99% | ||
| FCFM | 2.23% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.94 | ||
| Debt/FCF | 8.31 | ||
| Debt/EBITDA | 2.03 | ||
| Cap/Depr | 43.8% | ||
| Cap/Sales | 1.79% | ||
| Interest Coverage | 2.21 | ||
| Cash Conversion | 58.77% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.37 | ||
| Quick Ratio | 0.7 | ||
| Altman-Z | 1.6 |
ChartMill assigns a fundamental rating of 4 / 10 to HITI.
ChartMill assigns a valuation rating of 5 / 10 to HIGH TIDE INC (HITI). This can be considered as Fairly Valued.
HIGH TIDE INC (HITI) has a profitability rating of 4 / 10.
The Earnings per Share (EPS) of HIGH TIDE INC (HITI) is expected to grow by 121.5% in the next year.